Efficacy and Cost-Effectiveness of Anti-VEGF for Treating Diabetic Retinopathy in the Indian Population

PURPOSE: In the present study, we aimed to evaluate the efficacy, safety, and cost-effectiveness of the anti-vascular endothelial growth factor (anti-VEGF), namely ranibizumab (RBZ) or bevacizumab (BVZ), after either focal or grid or scatter laser photocoagulation, for the treatment of diabetic macu...

Descripción completa

Detalles Bibliográficos
Autores principales: Pramanik, Subhasish, Mondal, Lakshmi Kanta, Paine, Suman Kalyan, Jain, Sneha, Chowdhury, Subhankar, Ganguly, Upasana, Ghosh, Sayantan, Bose, Chiranjit, Bhattacharjee, Koena, Bhaduri, Gautam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364366/
https://www.ncbi.nlm.nih.gov/pubmed/34408392
http://dx.doi.org/10.2147/OPTH.S317771

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364366/
https://www.ncbi.nlm.nih.gov/pubmed/34408392
http://dx.doi.org/10.2147/OPTH.S317771

Ejemplares similares